Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

23.68USD
23 Jul 2014
Price Change (% chg)

$0.19 (+0.81%)
Prev Close
$23.49
Open
$23.48
Day's High
$23.98
Day's Low
$23.20
Volume
109,286
Avg. Vol
183,858
52-wk High
$24.65
52-wk Low
$9.41

RGEN.OQ

Chart for RGEN.OQ

About

Repligen Corporation is a United States-based life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. The Company manufactures Protein A, a critical reagent used to manufacture monoclonal antibody-based therapeutics. It also supplies... (more)

Overall

Beta: 1.21
Market Cap (Mil.): $752.62
Shares Outstanding (Mil.): 32.04
Dividend: --
Yield (%): --

Financials

  RGEN.OQ Industry Sector
P/E (TTM): 42.45 35.48 35.85
EPS (TTM): 0.55 -- --
ROI: 17.98 18.97 18.25
ROE: 18.38 19.75 19.12
Search Stocks

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $102.19 -0.28
Novartis AG (NOVN.VX) CHF80.20 -0.35
Roche Holding Ltd. (ROG.VX) CHF266.50 +0.50
Merck & Co., Inc. (MRK.N) $58.11 -0.32
Sanofi SA (SASY.PA) €76.93 -0.06
Amgen, Inc. (AMGN.OQ) $122.01 +0.90
Gilead Sciences, Inc. (GILD.OQ) $90.34 +1.01
Incyte Corporation (INCY.OQ) $48.98 +1.06

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks